. 2005 Mar;79(6):3653–3663. doi: 10.1128/JVI.79.6.3653-3663.2005

TABLE 5.

Frequencies of optimized epitope and variant epitope sequences in subject R before and after initiation of therapy for epitopes RLRPGGKKK_{(p17 20-28)} and TAFTIPSI_{(pol 295-302)} based on viral RNA sequencing

Time (wks) in therapy	Viral load	Sequence (no. of clones/total)
Time (wks) in therapy	Viral load	RLRPGGKKK	TAFTIPSI
0	98,597	`RLRPGGKKK (6/20)`	`TAFTIPSI (0/24)`
		`--------Q (11/20)`	`-------T (24/24)`
		`--------R (3/20)`	`-------M (0/24)`
9.5	478
14	ND^a	`RLRPGGKKK (14/16)`	`TAFTIPSI (14/14)`
		`--------Q (0/16)`	`-------T (0/14)`
		`--------R (2/16)`	`-------M (0/14)`
19	<400	`RLRPGGKKK (0/15)`	`TAFTIPSI (0/18)`
		`--------Q (15/15)`	`-------T (0/18)`
		`--------R (0/15)`	`-------M (18/18)`

ND, not determined.